GlassScriptPhysician profile
Theodore G Perry
NPI 1619081387
$138.19
in general payments reported to CMS, 2019-2025
6 companies · $16.82 in 2025
The $16.82 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $53.07 · 2021: $11.85 · 2023: $21.86 · 2024: $34.59 · 2025: $16.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $73.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $73.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $53.07 | 2020 | |
| Braintree Laboratories, INC. | $21.86 | 2023 | Suflave |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.27 | 2024 | Xifaxan |
| Hologic Sales and Service, LLC | $16.82 | 2025 | Magtrace, Sentimag |
| Janssen Biotech, INC. | $16.32 | 2024 | Simponi, Stelara, Tremfya |
| Checkpoint Surgical, INC | $11.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.